Pulse.

a daily field guide to health research that matters

◆ Console

‹ Fri · 30 Oct 2026
Standard addition

GLP-1 Receptor Agonists Decrease the Rate of Rupture, Cardiac Events, and Death in Patients with Abdominal Aortic Aneurysms.

GLP-1 drugs were linked to fewer aortic aneurysm ruptures, heart attacks, and deaths over five years in a large matched study.

This retrospective propensity-matched cohort study examined glp-1 receptor agonists decrease the rate of rupture, cardiac events, and death in patients with abdominal aortic aneurysms. The PubMed abstract reports in 13,722 matched patients per group, glp-1 receptor agonist use was associated with fewer abdominal aortic aneurysm ruptures, major cardiovascular events, and deaths over five years.

What the study was

Study design
Retrospective propensity-matched cohort study
Population
Patients with abdominal aortic aneurysm under imaging surveillance
Sample size
13722
Category
Treatment Innovation
Maturity
Validated
Journal
Journal of vascular surgery

Why it surfaced

Score reflects the retrospective propensity-matched cohort study design and relevance to Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; classification is limited to PubMed title, metadata, and abstract evidence.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.